Stock Earnings

Question 1

What are AstraZeneca PLC's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), AstraZeneca PLC has a total asset of $114,074, Net profit of $10,225

Question 2

What are the key financial ratios for AZN?

Accepted Answer

AstraZeneca PLC's Current ratio is 1.74, has a Net margin is 17.4, sales per share of $37.6.

Question 3

How is AstraZeneca PLC's revenue broken down by segment or geography?

Accepted Answer

AstraZeneca PLC largest revenue segment is Other, at a revenue of -4,002,000,000 in the most earnings release.For geography, UK Revenue is the primary market for AstraZeneca PLC, at a revenue of 4,359,000,000.

Question 4

Is AstraZeneca PLC profitable?

Accepted Answer

yes, according to the latest financial statements, AstraZeneca PLC has a net profit of $10,225

Question 5

Does AstraZeneca PLC have any liabilities?

Accepted Answer

yes, AstraZeneca PLC has liability of 65,407

Question 6

How many outstanding shares for AstraZeneca PLC?

Accepted Answer

AstraZeneca PLC has a total outstanding shares of 1,550.9

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	60,439	58,739	54,073	45,811	44,351	37,417
Revenue Growth (YoY)	10%	9%	18%	3%	19%	41%
Cost of Revenue	11,228	10,788	9,658	8,068	8,649	9,542
Gross Profit	49,211	47,951	44,415	37,743	35,702	27,875
Selling, General & Admin	16,490	16,079	15,495	14,649	13,512	11,519
Research & Development	14,174	13,801	12,211	10,271	9,612	8,519
Operating Expenses	34,453	33,855	31,732	28,827	26,874	22,973
Other Non Operating Income (Expenses)	--	-279	-291	-457	-441	-502
Pretax Income	12,914	12,402	8,691	6,899	2,501	-265
Income Tax Expense	2,521	2,169	1,650	938	-792	-380
Net Income	10,389	10,225	7,035	5,955	3,288	112
Net Income Growth	34%	45%	18%	81%	2,836%	-97%
Shares Outstanding (Diluted)	1,561	1,562	1,563	1,562	1,560	1,427
Shares Change (YoY)	0%	0%	0%	0%	9%	9%
EPS (Diluted)	6.65	6.55	4.5	3.81	2.11	0.08
EPS Growth	34%	46%	18%	81%	2,538%	-97%
Free Cash Flow	7,747	8,670	7,275	6,567	7,237	3,763
Free Cash Flow Per Share	4.96	5.55	4.65	4.2	4.63	2.63
Gross Margin	81.42%	81.63%	82.13%	82.38%	80.49%	74.49%
Operating Margin	24.41%	23.99%	23.45%	19.46%	19.9%	13.1%
Profit Margin	17.18%	17.4%	13.01%	12.99%	7.41%	0.29%
Free Cash Flow Margin	12.81%	14.76%	13.45%	14.33%	16.31%	10.05%
EBITDA	20,573	18,170	16,548	12,782	12,922	7,946
EBITDA Margin	34.03%	30.93%	30.6%	27.9%	29.13%	21.23%
D&A For EBITDA	5,815	4,074	3,865	3,866	4,094	3,044
EBIT	14,758	14,096	12,683	8,916	8,828	4,902
EBIT Margin	24.41%	23.99%	23.45%	19.46%	19.9%	13.1%
Effective Tax Rate	19.52%	17.48%	18.98%	13.59%	-31.66%	143.39%

AstraZeneca PLC (AZN) Price

AZN Stock Price Chart

AZN Income

Follow-Up Questions